2715. Toxicities and clinical consequences of valganciclovir prophylaxis in solid organ transplant recipients

BACKGROUND: Cytomegalovirus (CMV) commonly affects solid organ transplant (SOT) recipients, with increased risks of rejection, graft failure, and other infections. While valganciclovir (vGCV) prophylaxis is effective in preventing CMV, its use is sometimes hindered by toxicity. We examined the assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahoud, Chloe, Franceschi, Andres E, Reyes, Fabiola, Moshovitis, Dimitrios G, Achkar, Angela, Chakraborty, Antara, Balusu, Manu, Safiia, Jawad, Nussbaum, Eliezer Zachary, Letourneau, Alyssa R, Hammond, Sarah P, Kotton, Camille N, Koo, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678726/
http://dx.doi.org/10.1093/ofid/ofad500.2326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678726/
http://dx.doi.org/10.1093/ofid/ofad500.2326

Ejemplares similares